Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)

Clinical trial NCT02596243 · UNKNOWN

Trial details

NCT number: NCT02596243
Sponsor: Genexine, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia

Start date: 2015-08-01
Primary completion: 2018-03-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.